Aline Noizet is a global healthtech connector dedicated to helping startups turn innovation into real-world impact. As founder of Digital Health Connector, she mentors entrepreneurs, curates cross-border ecosystems, and works with investors and corporates to accelerate meaningful adoption in digital health.

​Anish Shindore is a digital health executive, advisor, and investor working with pharmaceutical companies and growth-stage startups across Europe and the US. He focuses on commercialization strategy, ecosystem integration, and what drives durable value creation in digital health.

Kyle Sherrill – From engineering at Eli Lilly to digital innovation at Novo Nordisk to launching early-stage startups across the US and EU, Kyle has more than 10 years of experience working across healthcare. He’s now an Investment Manager at Nina Capital, where he invests in early-stage health technology companies.

​Gil Bashe is FINN Partners Chair Global Health and Purpose, Editor in Chief of Medika Life, and author of the Amazon #1 new release in health policy Healing the Sick Care System: Why People Matter. He collaborates with leaders who are shaping the future of health and guides their ideas through the challenges that stand between progress and the people it serves.

​Gil has been tapped by PharmaVOICE as one of the 100 most inspiring people in healthcare, included in Fast Company’s 50 People to Watch in the New World of Work, chosen by MM&M as a Top 10 Innovation Catalyst, recognized by PRWeek and MM&M as a Top 50 Health Influencer, honored by the PRSA Health Academy for Excellence in Public Relations, awarded a Trailblazer Lifetime Achievement Award by PM360 and selected for the PR News Hall of Fame, PRWeek Top 30 Health Influencers and PRovoke Media Top 25 Innovators.

Todd Schwarzinger joined the Cleveland Clinic in January 2022 as a Partner with Cleveland Clinic Ventures, where he helps lead investment efforts in healthcare technology companies and supports the enterprise’s strategy to bring the most innovative technology to the Cleveland Clinic. Todd joined the Cleveland Clinic with over 20 years of investing, innovation leadership, investment banking, and consulting experience in healthcare and life sciences. His work focuses on identifying, supporting, and scaling transformative solutions that align with the Cleveland Clinic’s mission to enhance patient care and revolutionize healthcare delivery. Todd serves on the Boards of Cleveland Clinic portfolio companies Centerline Biomedical, Method AI, 1m, Sports Data Labs, Mobius Care, and Zehna Therapeutics.

Prior to joining the Cleveland Clinic, Todd led the launch of the Veale Institute for Entrepreneurship at Case Western Reserve University, where he remains an Adjunct Professor in Entrepreneurial Finance, and served as a Venture Partner with Refinery Ventures. Todd also served as a Managing Director and head of the Life Sciences and Healthcare practice at Silicon Valley Bank (SVB) for the Bay Area and Pacific Northwest. Todd and his team focused on lending, banking, and relationship solutions for healthcare clients of all life stages, spanning biopharma, medical device, digital health, diagnostics, and life science tools.

Prior to joining SVB, Todd was an Executive Director in the healthcare investment banking division at Morgan Stanley,  where he advised a broad range of medical device and biopharmaceutical clients on mergers and acquisitions, initial public offerings, the equity and debt capital markets. In his nearly nine-year career at Morgan Stanley across both London and New York, he was responsible for life sciences M&A transactions totaling over $5 billion and raised over $3 billion in capital markets transactions spanning North America, Europe, and Asia.

Todd holds a bachelor’s in finance from Miami University and received his MBA from the Fuqua School of Business at Duke University.